▶ 調査レポート

乾癬治療薬の世界市場2017

• 英文タイトル:Global Psoriasis Drugs Market Size, Status and Forecast 2022

QYResearchが調査・発行した産業分析レポートです。乾癬治療薬の世界市場2017 / Global Psoriasis Drugs Market Size, Status and Forecast 2022 / A04108379資料のイメージです。• レポートコード:A04108379
• 出版社/出版日:QYResearch / 2017年3月21日
• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥369,600 (USD3,300)▷ お問い合わせ
  Enterprise¥739,200 (USD6,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、乾癬治療薬の世界市場について調査・分析し、乾癬治療薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、乾癬治療薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。(※Sales:乾癬治療薬の販売量、Revenue:乾癬治療薬の売上高)

・乾癬治療薬市場概要
・乾癬治療薬のメーカー別販売量・メーカー別シェア
・乾癬治療薬の世界市場:種類別販売量・市場シェア
・乾癬治療薬の世界市場:用途別販売量・市場シェア
・乾癬治療薬の世界市場:地域別販売量・市場シェア
・乾癬治療薬のアメリカ市場規模
・乾癬治療薬の中国市場規模
・乾癬治療薬のヨーロッパ市場規模
・乾癬治療薬の日本市場規模
・乾癬治療薬の東南アジア市場規模
・乾癬治療薬のインド市場規模
・乾癬治療薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・乾癬治療薬のコスト分析・価格動向
・乾癬治療薬の産業チェーン(サプライチェーン分析)
・乾癬治療薬のマーケティング戦略・販売チャネル、流通業者
・乾癬治療薬市場への影響要因分析
・乾癬治療薬の世界市場予測
・乾癬治療薬のアメリカ市場予測
・乾癬治療薬の中国市場予測
・乾癬治療薬のヨーロッパ市場予測
・乾癬治療薬の日本市場予測
・乾癬治療薬の東南アジア市場予測
・乾癬治療薬のインド市場予測
・乾癬治療薬の種類別世界市場予測
・乾癬治療薬の用途別世界市場予測
...

This report studies the global Psoriasis Drugs market, analyzes and researches the Psoriasis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Amgen
Eli Lilly
Novartis
Merck
Johnson & Johnson
Pfizer
AstraZeneca
AbbVie
LEO Pharma
Biogen

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Psoriasis Drugs can be split into
TNF Inhibitors
Vitamin D Analogues or Combinations
Interleukin Blockers
Others

Market segment by Application, Psoriasis Drugs can be split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

レポート目次

Table of Contents

Global Psoriasis Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Psoriasis Drugs
1.1 Psoriasis Drugs Market Overview
1.1.1 Psoriasis Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Psoriasis Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Psoriasis Drugs Market by Type
1.3.1 TNF Inhibitors
1.3.2 Vitamin D Analogues or Combinations
1.3.3 Interleukin Blockers
1.3.4 Others
1.4 Psoriasis Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies

2 Global Psoriasis Drugs Competition Analysis by Players
2.1 Psoriasis Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Amgen
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Eli Lilly
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Novartis
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Merck
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Johnson & Johnson
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Pfizer
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 AstraZeneca
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 AbbVie
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 LEO Pharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Biogen
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Psoriasis Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments

4 Global Psoriasis Drugs Market Size by Type and Application (2012-2017)
4.1 Global Psoriasis Drugs Market Size by Type (2012-2017)
4.2 Global Psoriasis Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Psoriasis Drugs in Future
4.4 Top Consumer/End Users of Psoriasis Drugs

5 United States Psoriasis Drugs Development Status and Outlook
5.1 United States Psoriasis Drugs Market Size (2012-2017)
5.2 United States Psoriasis Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Psoriasis Drugs Development Status and Outlook
6.1 EU Psoriasis Drugs Market Size (2012-2017)
6.2 EU Psoriasis Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Psoriasis Drugs Development Status and Outlook
7.1 Japan Psoriasis Drugs Market Size (2012-2017)
7.2 Japan Psoriasis Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Psoriasis Drugs Development Status and Outlook
8.1 China Psoriasis Drugs Market Size (2012-2017)
8.2 China Psoriasis Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Psoriasis Drugs Development Status and Outlook
9.1 India Psoriasis Drugs Market Size (2012-2017)
9.2 India Psoriasis Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Psoriasis Drugs Development Status and Outlook
10.1 Southeast Asia Psoriasis Drugs Market Size (2012-2017)
10.2 Southeast Asia Psoriasis Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Psoriasis Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Psoriasis Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Psoriasis Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Psoriasis Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Psoriasis Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Psoriasis Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Psoriasis Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Psoriasis Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Psoriasis Drugs Market Size by Application (2017-2022)

12 Psoriasis Drugs Market Dynamics
12.1 Psoriasis Drugs Market Opportunities
12.2 Psoriasis Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Psoriasis Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Psoriasis Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Psoriasis Drugs Product Scope
Figure Global Psoriasis Drugs Market Size (Million USD) (2012-2017)
Table Global Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Psoriasis Drugs Market Share by Regions in 2016
Figure United States Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Psoriasis Drugs Market Share by Type in 2016
Figure TNF Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Vitamin D Analogues or Combinations Market Size (Million USD) and Growth Rate (2012-2017)
Figure Interleukin Blockers Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Psoriasis Drugs Market Share by Application in 2016
Figure Psoriasis Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Figure Psoriasis Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Figure Psoriasis Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table Psoriasis Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Psoriasis Drugs Market Size Share by Players in 2016
Figure Psoriasis Drugs Market Size Share by Players in 2017
Table Amgen Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Psoriasis Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Psoriasis Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Psoriasis Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Psoriasis Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Psoriasis Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Psoriasis Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Psoriasis Drugs Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Psoriasis Drugs Business Revenue Market Share in 2016
Table LEO Pharma Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of LEO Pharma (2012-2017)
Figure LEO Pharma Psoriasis Drugs Business Revenue Market Share in 2016
Table Biogen Basic Information List
Table Psoriasis Drugs Business Revenue (Million USD) of Biogen (2012-2017)
Figure Biogen Psoriasis Drugs Business Revenue Market Share in 2016
Table Global Psoriasis Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Psoriasis Drugs Market Size Share by Type in 2012
Figure Global Psoriasis Drugs Market Size Share by Type in 2013
Figure Global Psoriasis Drugs Market Size Share by Type in 2014
Figure Global Psoriasis Drugs Market Size Share by Type in 2015
Figure Global Psoriasis Drugs Market Size Share by Type in 2016
Figure Global Psoriasis Drugs Market Size Share by Type in 2017
Table Global Psoriasis Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2012
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2013
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2014
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2015
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2016
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Psoriasis Drugs
Figure United States Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Psoriasis Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Psoriasis Drugs Market Size Share by Players in 2016
Figure United States Psoriasis Drugs Market Size Share by Players in 2017
Figure EU Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Psoriasis Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Psoriasis Drugs Market Size Share by Players in 2016
Figure EU Psoriasis Drugs Market Size Share by Players in 2017
Figure Japan Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Psoriasis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Psoriasis Drugs Market Size Share by Players in 2016
Figure Japan Psoriasis Drugs Market Size Share by Players in 2017
Figure China Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Psoriasis Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Psoriasis Drugs Market Size Share by Players in 2016
Figure China Psoriasis Drugs Market Size Share by Players in 2017
Figure India Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Psoriasis Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Psoriasis Drugs Market Size Share by Players in 2016
Figure India Psoriasis Drugs Market Size Share by Players in 2017
Figure Southeast Asia Psoriasis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Psoriasis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Psoriasis Drugs Market Size Share by Players in 2016
Figure Southeast Asia Psoriasis Drugs Market Size Share by Players in 2017
Figure Global Psoriasis Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Psoriasis Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Psoriasis Drugs Market Size Share by Regions in 2017
Figure Global Psoriasis Drugs Market Size Share by Regions in 2022
Figure United States Psoriasis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Psoriasis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Psoriasis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Psoriasis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Psoriasis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Psoriasis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Psoriasis Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Psoriasis Drugs Market Size Share by Type in 2017
Figure Global Psoriasis Drugs Market Size Share by Type in 2022
Table Global Psoriasis Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2017
Figure Global Psoriasis Drugs Market Size (Million USD) by Application in 2022